• No results found

University of Groningen Advanced vascular imaging de Boer, Stefanie Amarens

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Advanced vascular imaging de Boer, Stefanie Amarens"

Copied!
7
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Advanced vascular imaging

de Boer, Stefanie Amarens

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from

it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date:

2017

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

de Boer, S. A. (2017). Advanced vascular imaging: Technical and clinical applications in type 2 diabetes.

Rijksuniversiteit Groningen.

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)
(3)
(4)

165

Bibliography

de Boer SA, Heerspink HJL, Juárez Orozco LE, van Roon AM, Kamphuisen PW, Smit AJ, Slart

RHJA, Lefrandt JD, Mulder DJ. Effect of linagliptin on pulse wave velocity in early type 2 diabetes: A randomized, double-blind, controlled 26-week trial (RELEASE). Diabetes Obes

Metab. 2017;19:1147-1154.

de Boer SA, Heerspink HJL, Lefrandt JD, Hovinga – de Boer MC, van Roon AM, Juárez

Orozco LE, Glaudemans AWJM, Kamphuisen PW, Slart RHJA, Mulder DJ. Effect of linagliptin

on arterial 18F-fluorodeoxyglucose positron emission tomography uptake A Randomized

Controlled Trial (RELEASE). J Am Coll Cardiol. 2017;69:1097-1098.

de Boer SA, Hovinga – de Boer MC, Heerspink HJL, Lefrandt JD, van Roon AM, Lutgers HL,

Glaudemans AWJM, Kamphuisen PW, Slart RHJA, Mulder DJ. Arterial stiffness is positively associated with 18F-fluorodeoxyglucose positron emission tomography-assessed subclinical

vascular inflammation in people with early type 2 diabetes. Diabetes Care. 2016;39:1440-1447.

de Boer SA, Lefrandt JD, Petersen JF, Boersma HH, Mulder DJ, Hoogenberg K. The effects of

GLP-1 analogues in obese, insulin-using type 2 diabetes in relation to eating behaviour. Int

J Clin Pharm. 2016;38:144-151.

de Boer SA, Boersma HH, Slart RHJA, Mulder DJ, Zeebregts CJAM.   Specialised imaging

to identify high-risk plaque. In: Greenhalgh RM, ed. Vascular and endovascular challenges

update. London: BIBA Publishing. BIBA Medical Ltd; 2016:5-12.

Hop H, de Boer SA, Reijrink M, Kamphuisen PW, de Borst MH, Pol R, Zeebregts CJAM, Hillebrands JL, Slart RHJA, Boersma HH, Doorduin J, Mulder DJ. 18F-sodium fluoride positron

emission tomography assessed microcalcifications in symptomatic and asymptomatic human carotid plaques. Submitted.

de Boer SA, Spoor DS, Slart RHJA, Mulder DJ, Reijrink M, Borra RJH, Kramer GM, Boellaard

R, Greuter MJ. Performance evaluation of a semi-automated method for 18F-FDG uptake in

abdominal visceral adipose tissue. Submitted.

Boersema J, de Boer SA, Heerspink HJL, Slart RHJA, Lefrandt JD, Mulder DJ. Skin advanced glycation end products are associated with computed tomography-assessed arterial calcification as a late marker of subclinical atherosclerosis in people with early type 2 diabetes. Submitted.

(5)

166

Bibliography

Reijrink M, de Boer SA, Spoor DS, Lefrandt JD, Heerspink HJL, Boellaard R, Greuter MJW, Borra RJH, Slart RHJA, Mulder DJ. Visceral adipose tissue volume is independently associated with 18F-FDG-PET assessed arterial inflammation in male patients with early type 2 diabetes

(6)
(7)

Referenties

GERELATEERDE DOCUMENTEN

described as the “legacy effect”. Therefore, achieving glycemic control as soon as possible, particularly early in the disease, may account for long-term beneficial CV

• Various imaging modalities such as nuclear molecular imaging, including PET and SPECT, and Bio-optical imaging can be used to identify the high-risk carotid plaque but need to

renal arteries, but was comparable between symptomatic and asymptomatic carotid plaques, potentially due to the advanced nature of atherosclerotic disease in our patients.

Criteria optimal settings for automated metabolic assessment of VAT The optimal threshold and erosion settings for the automated metabolic assessment of VAT had to fulfill

However, the relationship between premature arterial stiffness and arterial inflammation in patients with early type 2 diabetes without a history of cardiovascular disease has not

In this randomized placebo-controlled trial we showed that 26 weeks of treatment with the DPP-4 inhibitor linagliptin decreased PWV, a marker of arterial stiffness, in

In this randomized controlled trial we assessed the effect of 26 week’ treatment with the DPP-4 inhibitor lingaliptin on arterial 18 F-FDG uptake in early type 2 diabetes

In Chapter 5 we present our investigation of the association between arterial stiffness, assessed as aortic pulse wave velocity (PWV), and subclinical vascular inflammation, assessed